Banner
Want to know how to accelerate drug discovery for healthy ageing?

Come to the 2nd annual UK SPINE conference!
11th of November – 20th of November, online conference. Click here for the programme and signup.

Abstract artificial intelligence
UK SPINE KE: free flow of knowledge to accelerate innovations in ageing

Human ageing is a complex process with genetic, environmental and socioeconomic drivers. In order to produce a step change in addressing this challenge through medical innovation, a new way of working is required.

Communication netwrok banner
UK SPINE virtual seminar video

The video of the first UK SPINE virtual seminar is now on YouTube. The future of drug discovery for healthy ageing.

Audience bg
AIMdays

UK SPINE supports networking between academics and industry researchers through running a series of AIMdays. The AIMday format was developed by the University of Uppsala, and involves a series of non-confidential roundtable discussions led by industry on topics of their choosing. For details of upcoming AIMdays, check out the events section, or get in touch for more information.

Background  794698006
Working with Industry

UK SPINE encourages collaboration between academia and industry. We know that such collaborations are a key part in translating research breakthroughs to real-world impact. If your company is interested in working with academics in our network, please get in touch.

UK Knowledge Exchange Spine

The UK SPINE sets out to build a multi-lateral knowledge exchange network, concomitantly bringing together multi-disciplinary expertise from a range of HEIs, industry and the charitable sector, together with strong NHS partnerships focused on a common goal.

The Life Science Industrial Strategy set out to establish the UK as a global hub for clinical research and medical innovation, through novel and efficient partnerships across sectors.  Critical to this mission is knowledge exchange, which is better, faster and bigger.

Pivotal to the UK and all developed nations is the healthcare challenge to improve therapeutics for older people, reducing the impact of age related comorbidities, affordably, with accelerated timelines.  The UK SPINE project sets out to improve health in old age, by accelerating the development of new and affordable therapies which overcome the generic processes driving ageing and age related diseases.

Join us at our 2nd annual symposium, which will deliver a series of events focussed on research and innovation in geroscience and ageing therapeutics.

In this new study, the team of UK SPINE researchers puts forward a range of potential novel drug targets.

Polypharmacy in Older Adults - Challenges and Technological Advances

Spine Partners

UK dotted map with partners

University of Oxford

The University of Oxford are the lead UK SPINE partner and drive the target discovery effort of the UK SPINE by implementing the world-renowned capabilities of the structural genomics consortium.

University of Birmingham

As core partner of the UK SPINE the University of Birmingham drive the development of innovative clinical trials, new regulatory frameworks and patient public engagement within the healthy ageing space.

University of Dundee

As core partner in the UK SPINE the drug discovery unit (DDU) at the University of Dundee drives the development of the drug discovery, drug screening, and lead optimisation portfolio through their world-leading drug discovery pipeline.

Medicines Discovery Catapult

The Medicines Discovery Catapult turn high-impact science into new, high-value products and services that are used to accelerate innovative drug discovery.

The Francis Crick

The Francis Crick Institute is dedicated to understanding the fundamental biology underlying health and disease.

University of Oxford

The University of Oxford is a world leader in research for the benefit of society both in the UK and globally. They are the lead UK SPINE partners and drive the target discovery effort of the UK SPINE by implementing the world-renowned capabilities of the structural genomics consortium.

University of Birmingham

The University of Birmingham has major expertise in human ageing and age-related inflammatory diseases. As core partner of the UK SPINE they drive the development of innovative clinical trials, new regulatory frameworks and patient public engagement within the healthy ageing space.

University of Dundee

As core partner in the UK SPINE the drug discovery unit (DDU) at the University of Dundee drives the development of the drug discovery, drug screening, and lead optimisation portfolio through their world-leading drug discovery pipeline. Their work with the UKSPINE is funded through the Scottish Funding Council.

Medicines Discovery Catapult

The Medicines Discovery Catapult bring together a fragmented sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups in the UK. They turn high-impact science into new, high-value products and services that are used to accelerate innovative drug discovery.

The Francis Crick

The Francis Crick Institute is dedicated to understanding the fundamental biology underlying health and disease. They aim to increase our fundamental understanding of how to prevent, diagnose and treat illnesses such as cancer, heart disease, stroke, infections and neurodegenerative diseases.

Latest tweets